What are Chia Tai Tianqing Pharmaceutical Group Co., Ltd.'s marketed drugs?

Top marketed products include Anlotinib hydrochloride capsules, Baraclude tablets, blank Baraclude tablets, Blank maleate entecavir tablets, Carboplatin Injection, Dasatinib Tablets.

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

11 marketed · 32 in Phase 3

Quick facts

Marketed products

Anlotinib hydrochloride capsules · Oncology
Anlotinib is a multi-targeted tyrosine kinase inhibitor that blocks angiogenesis and tumor growth by inhibiting VEGFR, FGFR, PDGFR, and other kinases.
Baraclude tablets · Virology / Hepatology
Baraclude (entecavir) inhibits hepatitis B virus reverse transcriptase, blocking viral replication.
blank Baraclude tablets · Virology / Hepatology
Baraclude (entecavir) inhibits hepatitis B virus reverse transcriptase, blocking viral replication.
Blank maleate entecavir tablets · Virology / Hepatology
Entecavir inhibits hepatitis B virus reverse transcriptase and protein priming, blocking viral DNA replication.
Carboplatin Injection · Oncology
Carboplatin is a platinum-based chemotherapy agent that forms DNA crosslinks, preventing cancer cell replication and inducing apoptosis.
Dasatinib Tablets · Oncology
Dasatinib is a tyrosine kinase inhibitor that blocks BCR-ABL and multiple other kinases involved in cancer cell proliferation and survival.
Entecavir Tablet
Obeticholic Acid Tablets
Spiriva HandiHaler · Respiratory
Spiriva HandiHaler delivers tiotropium, a long-acting anticholinergic agent that blocks muscarinic receptors in airway smooth muscle to cause bronchodilation and improve airflow.
Spiriva®Handihaler®
Tresiba® · Diabetes
Tresiba is a long-acting basal insulin analog that binds to the insulin receptor to lower blood glucose by promoting glucose uptake and storage in peripheral tissues.

Phase 3 pipeline

AL2846 capsules · Oncology
AL2846 is a small-molecule inhibitor targeting a specific kinase involved in cancer cell proliferation and survival.
Angiotensin II Injection · Cardiovascular; Critical Care
Angiotensin II is a vasoactive peptide that binds to angiotensin II receptors to increase blood pressure and restore vascular tone in patients with hypotension.
Anlotinib(blank) · Oncology
Anlotinib is a multi-targeted tyrosine kinase inhibitor that blocks angiogenesis and tumor growth by inhibiting VEGFR, FGFR, PDGFR, and other kinases.
Anlotinib hydrochloride capsule + TQB2450 injection · Oncology
Anlotinib is a multi-target tyrosine kinase inhibitor combined with TQB2450, a PD-L1 inhibitor, to block tumor angiogenesis and enhance anti-tumor immune response.
Anlotinib hydrochloride capsules, Penpulimab injection · Oncology
Anlotinib is a multi-target tyrosine kinase inhibitor that blocks angiogenesis and tumor growth, while Penpulimab is a PD-1 inhibitor that enhances anti-tumor immune response.
Colistimethate sodium for injection · Infectious Disease
Colistimethate sodium is a prodrug of colistin that disrupts bacterial cell membranes by binding to lipopolysaccharides and phospholipids, leading to cell lysis and death.
Coly Mycin M Injectable Product · Infectious Disease
Colistin (polymyxin E) is a cyclic polypeptide antibiotic that disrupts bacterial cell membranes by binding to lipopolysaccharides and phospholipids, leading to cell lysis and death.
Docetaxel injection · Oncology
Docetaxel stabilizes microtubules by binding to β-tubulin, preventing their depolymerization and causing cell cycle arrest and apoptosis in cancer cells.
Fluvestrin injection · Cardiovascular / Regenerative Medicine
Fluvestrin is a recombinant human vascular endothelial growth factor (VEGF) that promotes angiogenesis and improves blood flow to ischemic tissues.
Gemcitabine Hydrochloride Injection · Oncology
Gemcitabine is a nucleoside analog that inhibits ribonucleotide reductase and gets incorporated into DNA, causing chain termination and cell death.
Gemzar · Other
Meropenem for Injection · Infectious Disease
Meropenem is a broad-spectrum beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.
Nelarabine injection · Oncology
Nelarabine is a prodrug that is converted to arabinosyl guanine, which inhibits ribonucleotide reductase and DNA synthesis, leading to apoptosis in T-cell malignancies.
Pemetrexed disodium f Injection · Oncology
Pemetrexed is a folate antagonist that inhibits multiple enzymes involved in nucleotide synthesis, disrupting DNA and RNA production in cancer cells.
Perjeta + Trastuzumab + Docetaxel · Oncology
This combination uses two HER2-targeting monoclonal antibodies (Perjeta and Trastuzumab) plus a taxane chemotherapy to block HER2 signaling and inhibit microtubule dynamics in HER2-positive breast cancer cells.
Placebo capsules, Letrozole, Anastrozole, Tamoxifen · Oncology
Letrozole and Anastrozole are aromatase inhibitors, which block the production of estrogen in the body. Tamoxifen is a selective estrogen receptor modulator (SERM), which blocks estrogen receptors in breast tissue.
Toripalimab injection · Oncology
Toripalimab is a monoclonal antibody that blocks PD-1 on immune cells, allowing them to recognize and attack cancer cells.
TQ-B211 · Diabetes
TQ-B211 is a small molecule that targets the SGLT2 receptor.
TQ-B3139 · Oncology
TQ-B3139 is a tyrosine kinase inhibitor that targets multiple kinases involved in cancer cell proliferation and survival.
TQ-B3234 capsules
TQ-B3234 capsules' mechanism is not publicly available.
TQB2303 · Oncology
TQB2303 is a small molecule targeting the PD-1/PD-L1 pathway.
TQB2440 injection + Trastuzumab + Docetaxel · Oncology
TQB2440 injection is a targeted therapy that works by inhibiting the PD-1/PD-L1 pathway, while Trastuzumab is a monoclonal antibody that targets the HER2/neu receptor, and Docetaxel is a chemotherapy medication that works by inhibiting cell division.
TQB2450+Anlotinib · Oncology
TQB2450 is a tyrosine kinase inhibitor, and Anlotinib is a vascular endothelial growth factor receptor (VEGFR) inhibitor.
TQB2450(blank) · Oncology
TQB2450 is a monoclonal antibody targeting PD-1.
TQB3454 Tablets · Oncology
TQB3454 is designed to inhibit the activity of a specific enzyme involved in the progression of certain cancers.
TQB3473 · Oncology
TQB3473 is a small molecule drug that targets the PD-1/PD-L1 pathway.
TQB3473 Tablets
TQB3473 Tablets' mechanism of action is not publicly available.
TQB3616 capsule · Oncology
TQB3616 capsule is a small molecule drug that targets the PD-1/PD-L1 pathway.
TQB3616 capsules · Oncology
TQB3616 is a small-molecule inhibitor that targets fibroblast growth factor receptor (FGFR) signaling pathways.
TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen · Oncology
Letrozole and Anastrozole are non-steroidal, selective aromatase inhibitors, while Tamoxifen is a selective estrogen receptor modulator.
TQC3721 suspension for inhalation · Respiratory
TQC3721 suspension for inhalation is a medication that targets the respiratory system to treat a specific condition.
TQZ2451 · Oncology
TQZ2451 is a small molecule drug that targets the molecular target.

Phase 2 pipeline

Abiraterone acetate tablets · Oncology
CYP17 inhibitor
Entecavir dispersible tablets · Infectious Disease
Inhibits hepatitis B virus DNA polymerase
Faropenem（high dose group）
Faropenem（low-dose group)
prednisone acetate tablets
Salbutamol sulfate inhalation aerosol
Sunitinib maleate
TQ-A3334
TQ-B3101
TQ-B3525
TQ05105 Tablets
TQA3334 Tablet
TQA3526
TQA3605 tablets plus NAs
TQB3702 tablets
TQC3721 inhalation powder
TQH2722 injection 600mg-300mg
TQH2929 Injections

Phase 1 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: